EUVIMEDEUVIMED entdecken
Crossref

Hypoalbuminemia as a relapse risk factor after high dose chemotherapy and autologous stem cell transplantation in patients with Hodgkin’s lymphoma

Paweł Koźlik, Monika Długosz-Danecka, Renata Pacholczak, Agata Bryk, Agata Krawczyk, Wojciech Jurczak

OncoReview · 2019

DOI: 10.24292/01.or.101218 ↗

Kurz gefasst

Fachartikel in der Zeitschrift OncoReview, 2019. Verfasst von Paweł Koźlik und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Koźlik, P., Długosz-Danecka, M., Pacholczak, R., Bryk, A., Krawczyk, A., & Jurczak, W. (2019). Hypoalbuminemia as a relapse risk factor after high dose chemotherapy and autologous stem cell transplantation in patients with Hodgkin’s lymphoma. OncoReview. https://doi.org/10.24292/01.or.101218

Vancouver

Koźlik P, Długosz-Danecka M, Pacholczak R, Bryk A, Krawczyk A, Jurczak W. Hypoalbuminemia as a relapse risk factor after high dose chemotherapy and autologous stem cell transplantation in patients with Hodgkin’s lymphoma. OncoReview. 2019. doi:10.24292/01.or.101218

BibTeX
@article{Kolik2019,
  author = {Koźlik, Paweł and Długosz-Danecka, Monika and Pacholczak, Renata and Bryk, Agata and Krawczyk, Agata and Jurczak, Wojciech},
  title = {Hypoalbuminemia as a relapse risk factor after high dose chemotherapy and autologous stem cell transplantation in patients with Hodgkin’s lymphoma},
  journal = {OncoReview},
  year = {2019},
  doi = {10.24292/01.or.101218}
}
Kostenlos starten →